Anavex Life Sciences Corp. (LON:0HFR)
8.51
-0.29 (-3.35%)
At close: Feb 21, 2025
Anavex Life Sciences Statistics
Total Valuation
LON:0HFR has a market cap or net worth of GBP 561.87 million. The enterprise value is 466.33 million.
Market Cap | 561.87M |
Enterprise Value | 466.33M |
Important Dates
The last earnings date was Wednesday, February 5, 2025.
Earnings Date | Feb 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +4.13% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 82.47M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 6.34 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -12.56 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.45
Current Ratio | 9.45 |
Quick Ratio | 9.39 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -37.72% and return on invested capital (ROIC) is -26.87%.
Return on Equity (ROE) | -37.72% |
Return on Assets (ROA) | -24.34% |
Return on Invested Capital (ROIC) | -26.87% |
Return on Capital Employed (ROCE) | -47.77% |
Revenue Per Employee | n/a |
Profits Per Employee | -884,181 |
Employee Count | 42 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +57.58% in the last 52 weeks. The beta is 0.69, so LON:0HFR's price volatility has been lower than the market average.
Beta (5Y) | 0.69 |
52-Week Price Change | +57.58% |
50-Day Moving Average | 9.83 |
200-Day Moving Average | 6.77 |
Relative Strength Index (RSI) | 41.95 |
Average Volume (20 Days) | 4,757 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 13.31 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -42.32M |
Pretax Income | -37.14M |
Net Income | -37.14M |
EBITDA | n/a |
EBIT | -42.32M |
Earnings Per Share (EPS) | -0.44 |
Balance Sheet
Cash & Cash Equivalents | 96.47M |
Total Debt | n/a |
Net Cash | 96.47M |
Net Cash Per Share | n/a |
Equity (Book Value) | 88.60M |
Book Value Per Share | 1.04 |
Working Capital | 88.60M |
Cash Flow
Operating Cash Flow | -28.45M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
LON:0HFR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.13% |
Shareholder Yield | -4.13% |
Earnings Yield | -6.61% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |